The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rasagiline Teva 1mg tablets

1 milligram(s) Tablet

Teva B.V.PA1986/017/001

Main Information

Trade NameRasagiline Teva 1mg tablets
Active SubstancesRasagiline mesilate
Strength1 milligram(s)
Dosage FormTablet
Licence HolderTeva B.V.
Licence NumberPA1986/017/001

Group Information

ATC CodeN04BD Monoamine oxidase B inhibitors
N04BD02 rasagiline

Status

Authorised/WithdrawnAuthorised
Licence Issued04/12/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back